Skip to main content

Legal economy

Advanced search options

The creation of the guidelines has been financially supported by the CRT Foundation. It was greatly influenced by the analysis that UNICRI conducted in its report entitled Counterfeiting: a global spread, a global threat, first published in 2007.

The publication focuses on two distinct aspects of the counterfeiting problem and both of them play a pivotal role in addressing the complex nature of counterfeiting:

The first report Counterfeiting, a global spread, a global threat, published by UNICRI in 2007, provides a global assessment of organized criminal involvement in counterfeiting. It presents a general overview of counterfeiting, supported by data and statistics, and contains an analysis of the consequences of the crime for human society. It highlights its economic and social impacts and the risks that certain counterfeit goods may cause to consumers’ health and safety.

The SAVEmed (Microstructure secured and self-verifying medicines) project is funded by the European Commission under the Seventh Framework Programme for Research and Technological Development (FP7). The various partners involved possess expertise in pharmaceutical production, packaging and anti-counterfeiting strategies.

Counterfeit pharmaceuticals are among the counterfeit products with the greatest potential of harm for consumers’ health. However, for such a dangerous threat, the topic has received a negligible amount of attention from the media and the general public.

Counterfeit medicines have become a highly profitable criminal industry run by transnational criminal organizations. The issue has affected international communities in terms of growth, industrial and commercial turnover, social development, improvement of people’s living conditions, and human security.

Subscribe to Legal economy